DMK Pharmaceuticals Corporation

LSE:0A4X Voorraadrapport

Marktkapitalisatie: US$10.0

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

DMK Pharmaceuticals Beheer

Beheer criteriumcontroles 0/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Eddie Glover

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEOno data
Eigendom CEOn/a
Management gemiddelde ambtstermijngeen gegevens
Gemiddelde ambtstermijn bestuurgeen gegevens

Recente managementupdates

Recent updates


CEO

Eddie Glover (74 yo)

no data

Tenure

Mr. Eddie Wabern Glover serves as Chief Executive Officer of US Compounding Inc at DMK Pharmaceuticals Corporation (formerly known as Adamis Pharmaceuticals Corporation). He co-founded US Compounding, Inc....